Georgina L. Ryland

The molecular origin and taxonomy of mucinous ovarian carcinoma

Dane Cheasley, Matthew J. Wakefield, Georgina L. Ryland et al. · Nature Communications · 2019 · 187 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Loss of heterozygosity: what is it good for?

Georgina L. Ryland, Maria Doyle, David L. Goode et al. · BMC Medical Genomics · 2015 · 128 citations · Full text

Life Sciences, Genetics, Oncology +16

Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants

Adam Bournazos, Lisa G. Riley, Shobhana Bommireddipalli et al. · Genetics in Medicine · 2021 · 104 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study

Adrian Minson, Nada Hamad, Chan Y. Cheah et al. · Blood · 2023 · 67 citations

Medicine, Hematology, Oncology +17

ALLSorts: an RNA-Seq subtype classifier for B-cell acute lymphoblastic leukemia

Breon Schmidt, Lauren M. Brown, Georgina L. Ryland et al. · Blood Advances · 2022 · 64 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +10